GSK plc (GSK) is a Healthcare stock tracked by StreetAlpha. It last closed at $49.24 on Nov 17, down 2.34% on the day. GSK reports earnings on Wed, Feb 3, 2027. In the past 30 days there were 3 dark pool prints totaling $2.1M, the largest $978K.
From GSK's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 6). Figures are in GBP. Per share figures are left out because the US listing can represent a different number of shares.
Only 1 firm rated GSK in the past 90 days, not enough for a consensus
Average 12-month target
$55.90
▲ 13.5% upside
Based on 1 analyst who set a price target on GSK in the past 90 days. The average target is $55.90, with a high of $55.90 and a low of $55.90, compared with the last close of $49.24.
Low $55.90Avg $55.90High $55.90
Blue marker: last close $49.24
Highest target$55.90
Average target$55.90
Lowest target$55.90
Latest rating changes
JefferiesDowngrade
Oct 29Hold$55.90
Date
Firm
Action
Rating
Price target
Oct 29
Jefferies
Downgrade
Hold
$55.90
Loading…
Technical Analysis
GSK · as of the Nov 17 close · updated after every close
Moving sideways
The stock is 2% below its 20 day and 0% below its 50 day average. It is 6% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 46). The nearest support is the Pivot S1 at $49.00, and the nearest resistance the 50 day average at $49.32.
Short trendNeutral
Long trendBearish
MomentumFading
StretchNormal
VolatilityHigh, 2.4%/day
Key levels
$61.7052 week high+25.3%
$52.38200 day average+6.4%
$51.32Swing high (Sep 21)+4.2%
$50.45100 day average+2.5%
$50.2420 day average+2.0%
$49.63Pivot R1+0.8%
$49.39Pivot+0.3%
$49.3250 day average+0.2%
$49.24Last close
$49.00Pivot S1−0.5%
$48.86Swing low (Aug 14)−0.8%
$45.8152 week low−7.0%
Indicators
RSI (14)
45.88
Middle of its range
Neutral
MACD
0.29
Below its signal line
Bearish
Stochastic
55.8
Middle of its range
Neutral
ADX (14)
11.7
No clear trend
Williams %R
-68.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
-75.8
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.1%
Change over 10 sessions
Bullish
ATR (14)
$1.17
Typical daily range, 2.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumImproving
StretchNormal
VolatilityNormal, 5.5%/day
Key levels
$61.7052 week high+25.3%
$52.38200 day average+6.4%
$51.32Swing high (Sep 21)+4.2%
$50.45100 day average+2.5%
$50.2420 day average+2.0%
$49.63Pivot R1+0.8%
$49.39Pivot+0.3%
$49.3250 day average+0.2%
$49.24Last close
$49.00Pivot S1−0.5%
$48.86Swing low (Aug 14)−0.8%
$45.8152 week low−7.0%
Indicators
RSI (14)
47.08
Middle of its range
Neutral
MACD
-0.52
Above its signal line
Bullish
Stochastic
58.3
Middle of its range
Neutral
ADX (14)
8.9
No clear trend
Williams %R
-52.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
-22.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.3%
Change over 10 sessions
Bullish
ATR (14)
$2.68
Typical daily range, 5.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200–
What happened before, for GSK
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GSK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow GSK usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How GSK has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GSK is in one of them and how their past GSK trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.